If CNSP (Nasdaq) Passes Their FDA Approved Phase 2... If CNSP Pharmaceuticals Passes Their Phase 2, after some DD last night, and Analysts Reviews, This Could Be a $300-$400 stock!
My Rating is Super Strong Buy Here @ $2!
Buy! Buy! Buy! As JC Always Says!